MDXH
MDxHealth SAPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- B Aug 13 1 insider buy $1000.0K at $0.4540
- X Aug 14 Short interest jumps 36.6% to 1.45M
- E Aug 14 Trading halt: Halt Resumed: MDXH — trading resumed after LUDP (Volatilit…
- R Sep 17 Bleichroeder LP, a 10% stockholder of MDxHealth SA, filed a Form 144…
- R Oct 15 Bleichroeder LP filed an amended Schedule 13D for MDxHealth SA, disc…
- R Oct 15 mdxhealth pre-announced Q3 2026 revenue of ~$22.7M (flat YoY), suspe…
- R Oct 16 MDxHealth announced preliminary Q3 2026 revenue of $22.7M (flat YoY)…
- A Oct 19 BTIG downgrades
Signal stack
Where each data set points today.
- InsidersBULLISH
1 insider bought $1000.0K at an average $0.4540. No open-market sales. Price is 57% below their cost.
- InstitutionsMIXED
Q2 2026: 4 added (0 new), 4 trimmed or exited.
- AnalystsBULLISH
9 of 12 rate it Buy or better. Every target is above the price.
- EstimatesRISING
Current-quarter EPS estimate −$0.162 → −$0.092 over 90 days. 5 up, 0 down in 30 days.
- TrendDOWNTREND
67% below its 50-day average. New closing low $0.1830 on Oct 23.
- SocialQUIET
No Reddit mentions this week. Last mention Oct 18.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| CITADEL ADVISORS LLC | DOUBLED | $209.3K |
| MILLENNIUM MANAGEMENT LLC | TRIM | $93.8K |
| HRT FINANCIAL LP | DOUBLED | $75.0K |
| BlackRock, Inc. | ADD | $60.4K |
| Lido Advisors, LLC | ADD | $8.3K |
| MORGAN STANLEY | NEAR_EXIT | $313.00 |
| BARCLAYS PLC | NEAR_EXIT | $7.00 |
| UBS Group AG | NEAR_EXIT | $1.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
12 analystsPrice is below the lowest target. Median implies +413%.Targets as of Oct 27, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 19, 2026 | BTIG DOWNGRADE | Neutral |
| Aug 21, 2026 | BTIG MAINTAIN | Buy |
| Aug 14, 2026 | Lake Street MAINTAIN | Buy |
| May 14, 2026 | Lake Street MAINTAIN | Buy |
| May 14, 2026 | TD Cowen MAINTAIN | Buy |
| May 14, 2026 | BTIG MAINTAIN | Buy |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Aug 13, 2026 | MVM Partners, LLC Director | BUY | $1000.0K |
| Jun 1, 2026 | McGarrity Michael Chief Executive Officer | AWARD | 329,800 sh |
| Jun 1, 2026 | Sollee Joseph See Remarks | AWARD | 83,000 sh |
| Jun 1, 2026 | Bellano John Chief Commercial Officer | AWARD | 116,000 sh |
| Jun 1, 2026 | Windels Hilde Director | AWARD | 10,000 sh |
| Jun 1, 2026 | Holder Michael Director | AWARD | 10,000 sh |
| Jun 1, 2026 | Siegel Sanford Jay Director | AWARD | 10,000 sh |
| Jun 1, 2026 | Hoffman Koen Director | AWARD | 10,000 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.09 | -$0.11–-$0.06 | +0.0% | $25.2M |
| Next Q | -$0.08 | -$0.10–-$0.05 | +0.0% | $26.8M |
| Current FY | -$0.46 | -$0.46–-$0.46 | +0.0% | $97.7M |
| Next FY | -$0.38 | -$0.38–-$0.38 | +0.0% | $110.7M |
Short side
FINRA· Oct 15, 2026| Aug 14, 2026 | Volatility Pause | Resumed |
| Aug 14, 2026 | Volatility Pause | Resumed |
| Aug 14, 2026 | Volatility Pause | Resumed |
| Aug 14, 2026 | Volatility Pause | Resumed |
SecBot reports
11 filings · 2 press releases · 0 bullish · 7 bearish · 1 mixed · 3 neutral- BEARISH 6-KOct 16, 2026
MDxHealth announced preliminary Q3 2026 revenue of $22.7M (flat YoY), suspended its full-year 2026…
The guidance suspension and 11% decline in core tissue-based test volumes are the key negatives. Monitor the November 12 earnings call for details on corrective actions and sales force…
- BEARISH SC 13D/AOct 15, 2026
Bleichroeder LP filed an amended Schedule 13D for MDxHealth SA, disclosing beneficial ownership of…
The activist's sustained selling over a month signals waning conviction or a strategic exit. Monitor for further 13D amendments and any change in stated purpose; if selling continues, the stock may…
- BEARISH PRESS-RELEASEOct 15, 2026
mdxhealth pre-announced Q3 2026 revenue of ~$22.7M (flat YoY), suspended its full-year 2026…
Monitor the full Q3 earnings call on Nov 12 for details on sales force stabilization and corrective actions. The guidance suspension and flat revenue with declining core tissue volumes suggest…
- BEARISH 144Sep 17, 2026
Bleichroeder LP, a 10% stockholder of MDxHealth SA, filed a Form 144 on September 17, 2026…
Monitor for actual sale execution via subsequent Form 4 filings. The large proposed sale by a 10% holder could signal reduced conviction or liquidity needs; watch for any concurrent negative company…
All MDXH filing & press-release reports (13)
- 6-K reportOct 16, 2026
- SC 13D/A reportOct 15, 2026
- PRESS-RELEASE reportOct 15, 2026
- 144 reportSep 17, 2026
- 6-K reportSep 3, 2026
- 6-K reportAug 13, 2026
- PRESS-RELEASE reportAug 13, 2026
- 6-K reportJul 24, 2026
- PRESS-RELEASE reportJul 2, 2026
- 6-K reportApr 29, 2026
- 3 reportApr 13, 2026
- 3 reportApr 10, 2026
- PRESS-RELEASE reportMar 16, 2026